Close Menu

Beckman Coulter's acquisition of Clinical Data's Cogenics division, announced last week, will add more services, a wider geographic reach, and a CLIA-certified lab to its Agencourt Biosciences business.

Up until now, Agencourt has been focusing primarily on DNA sequencing services and nucleic acid purification products. The company, based in Beverly, Mass., is equipped with more than 30 ABI 3730xl sequencers, two Roche/454 GS FLX instruments, two Applied Biosystems SOLiD 3 instruments, and a recently purchased Illumina Genome Analyzer II.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

NPR reports that the patient who underwent a CRISPR-based treatment for sickle cell disease is doing well.

Resistance to ash dieback disease among some UK ash trees appears polygenic, the Independent reports.

In Nucleic Acids Research this week: sequencing strategy for flash-frozen brain tissue bank samples, new version of ChlamDB, and more.

A UK woman is suing three National Health Service Trusts for not telling her about her father's Huntington's disease diagnosis, the BBC reports.

Dec
04
Sponsored by
BC Platforms

This webinar will discuss what it takes to begin realizing precision medicine in a comprehensive clinical infrastructure, with insights from the Colorado Center for Personalized Medicine (CCPM).